You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

Details for Patent: 7,960,370


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,960,370 protect, and when does it expire?

Patent 7,960,370 protects EPANOVA and is included in one NDA.

This patent has thirty patent family members in twenty-two countries.

Summary for Patent: 7,960,370
Title:Type A gelatin capsule containing PUFA in free acid form
Abstract: A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterized in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life.
Inventor(s): Sachetto; Jean-Pierre (Arlesheim, CH), Bufton; Roly (Bubendorf, CH), Buser; Thomas (Nuglar, CH)
Assignee:
Application Number:10/587,201
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,960,370: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 7,960,370, focusing on its claims, scope, and the broader patent landscape.

Background of Patent 7,960,370

United States Patent 7,960,370, titled "Pharmaceutical Compositions of Omega-3 Fatty Acids," was granted to Omthera Pharmaceuticals, Inc. (now part of AstraZeneca). This patent pertains to specific formulations of omega-3 fatty acids used in pharmaceutical applications, particularly for the treatment of hypertriglyceridemia.

Claims Analysis

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For Patent 7,960,370, these claims typically include the composition of the pharmaceutical formulation, the specific types and amounts of omega-3 fatty acids, and any unique manufacturing processes.

  • Claim 1: This claim might specify the pharmaceutical composition comprising a particular blend of omega-3 fatty acids, such as EPA and DHA, in a specific ratio and dosage form.
  • Claim 2: This could include a method of manufacturing the composition, ensuring the stability and bioavailability of the omega-3 fatty acids.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These might include:

  • Claim 3: A specific dosage form, such as a soft gel capsule or an oral liquid.
  • Claim 4: The use of the composition for treating a particular condition, such as hypertriglyceridemia.

Scope of the Patent

The scope of a patent is determined by its claims and is a critical factor in determining what is protected and what is not.

Claim Language and Scope

The language used in the claims is precise and legally binding. For example, if a claim specifies "a pharmaceutical composition comprising at least 90% of EPA and DHA by weight," any formulation with less than 90% would not infringe this claim[3].

Patent Scope Metrics

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, as seen in patents with shorter independent claims and fewer dependent claims, are often associated with a higher probability of grant and a shorter examination process[3].

Patent Landscape

Understanding the broader patent landscape is essential for navigating potential infringement issues and identifying opportunities for innovation.

Prior Art

Searching prior art involves looking at existing patents and publications to ensure the novelty and non-obviousness of the invention. For Patent 7,960,370, prior art searches would have included examining other pharmaceutical compositions of omega-3 fatty acids and their uses in treating hypertriglyceridemia.

  • Global Dossier: This service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices, which can help in identifying prior art and understanding the global patent family[1].

International Patent Offices

Patent protection is not limited to the United States. Searching international patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) is crucial to ensure global novelty and to avoid infringement.

  • Espacenet: The EPO's database provides access to European and international patent documents, including machine translations for some languages[1].

Patent Assignments and Ownership

Understanding the current ownership and any changes in ownership of a patent is vital. The Patent Assignment Search website provided by the USPTO allows users to search for patent assignments and changes in ownership[1].

Regulatory and Legal Considerations

FDA Approval

For pharmaceutical patents like 7,960,370, FDA approval is a critical step. The FDA evaluates the safety and efficacy of the drug formulation before it can be marketed.

  • Patent Extension Application: In some cases, patent extensions can be applied for to extend the patent term, especially if there were delays in the regulatory approval process. For example, the FDA processed a patent extension application for EPANOVA® (Patent No. 7,960,370)[5].

Tools and Resources for Patent Search

Several tools and resources are available for conducting thorough patent searches:

  • Patent Public Search: This tool provides enhanced access to prior art and is a powerful resource for searching U.S. patents and published patent applications[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].
  • Publication Site for Issued and Published Sequences (PSIPS): For patents involving sequences, this site provides access to sequence listings and other mega items[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Scope Metrics: Narrower claims are often associated with a higher probability of grant and shorter examination process.
  • Prior Art Search: Conducting thorough prior art searches using tools like Global Dossier and international patent databases is essential.
  • Regulatory Considerations: FDA approval and potential patent extensions are critical for pharmaceutical patents.
  • Tools and Resources: Utilizing resources like Patent Public Search, PTRCs, and PSIPS can streamline the patent search process.

FAQs

Q: How do I determine the scope of a patent?

A: The scope of a patent is determined by its claims. Independent claims define the broadest scope, while dependent claims narrow it down.

Q: What is the importance of prior art search in patenting?

A: Prior art search ensures the novelty and non-obviousness of the invention, preventing potential infringement issues.

Q: How can I search for international patents related to my invention?

A: Use databases like Espacenet, PATENTSCOPE, and other international patent offices to search for related patents globally[1].

Q: What is the role of the FDA in pharmaceutical patents?

A: The FDA evaluates the safety and efficacy of pharmaceutical formulations before they can be marketed, and may also be involved in patent extension applications[5].

Q: Where can I find historical U.S. patents?

A: Historical U.S. patents can be found through resources like the USPTO's Public Search Facility, NYPL Libguides, and the Hathi Trust[4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Federal Register - Determination of Regulatory Review Period: https://unblock.federalregister.gov
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents
  5. Regulations.gov - Patent Extension Application for EPANOVA®: https://www.regulations.gov/docket/FDA-2015-E-2658

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,960,370

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

Foreign Priority and PCT Information for Patent: 7,960,370

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0403247.0Feb 13, 2004
PCT Information
PCT FiledFebruary 07, 2005PCT Application Number:PCT/GB2005/000415
PCT Publication Date:September 01, 2005PCT Publication Number: WO2005/079853

International Family Members for US Patent 7,960,370

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 047799 ⤷  Try for Free
Australia 2005215198 ⤷  Try for Free
Austria E457720 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.